These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15819171)

  • 41. A protease isolated from human plasma activating factor VII independent of tissue factor.
    Römisch J; Feussner A; Vermöhlen S; Stöhr HA
    Blood Coagul Fibrinolysis; 1999 Dec; 10(8):471-9. PubMed ID: 10636458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A modified thrombin generation test for the measurement of factor VIII concentrates.
    McIntosh JH; Owens D; Lee CA; Raut S; Barrowcliffe TW
    J Thromb Haemost; 2003 May; 1(5):1005-11. PubMed ID: 12871369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation.
    Rietveld IM; Schreuder M; Reitsma PH; Bos MHA
    Thromb Res; 2018 Dec; 172():104-109. PubMed ID: 30408635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.
    Dai L; Bevan D; Rangarajan S; Sørensen B; Mitchell M
    Haemophilia; 2011 Sep; 17(5):e944-8. PubMed ID: 21371192
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
    Atkinson HM; Mewhort-Buist TA; Berry LR; Chan AK
    Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The subunit structure of normal and hemophilic factor VIII.
    Shapiro GA; Andersen JC; Pizzo SV; McKee PA
    J Clin Invest; 1973 Sep; 52(9):2198-210. PubMed ID: 4199414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An approach to assigning in vitro potency to unfractionated and low molecular weight heparins based on the inhibition of prothrombin activation and catalysis of thrombin inhibition.
    Ofosu FA; Smith LM; Anvari N; Blajchman MA
    Thromb Haemost; 1988 Oct; 60(2):193-8. PubMed ID: 2851191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunoblot analysis shows changes in factor VIII inhibitor chain specificity in factor VIII inhibitor patients over time.
    Fulcher CA; Lechner K; de Graaf Mahoney S
    Blood; 1988 Oct; 72(4):1348-56. PubMed ID: 2458782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polyphosphate as a general procoagulant agent.
    Smith SA; Morrissey JH
    J Thromb Haemost; 2008 Oct; 6(10):1750-6. PubMed ID: 18665922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemophilia A in cardiac operations: a model of reduced thrombin generation.
    Lison S; Spannagl M; Dietrich W;
    Ann Thorac Surg; 2011 May; 91(5):1606-8. PubMed ID: 21524474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antithrombotic and hemorrhagic effects of DX-9065a, a direct and selective factor Xa inhibitor: comparison with a direct thrombin inhibitor and antithrombin III-dependent anticoagulants.
    Morishima Y; Tanabe K; Terada Y; Hara T; Kunitada S
    Thromb Haemost; 1997 Nov; 78(5):1366-71. PubMed ID: 9408021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Assessment of anti-factor Xa activity for heparin and related products by chromogenic assays and thrombin generation tests].
    Suzuki A; Kaneko M; Kanno N; Yatomi Y
    Rinsho Byori; 2013 Jul; 61(7):567-75. PubMed ID: 24205696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns.
    Streif W; Paes B; Berry L; Andrew M; Andreasen RB; Chan AK
    Blood Coagul Fibrinolysis; 2000 Jun; 11(4):349-57. PubMed ID: 10847422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of thrombin generation for paired-platelet-rich plasma collected with and without corn trypsin inhibitor from hemophiliacs treated with factor-VIII inhibitor bypassing agents.
    Tripodi A; Chantarangkul V; Mancuso ME; Lemma L; Clerici M; Santagostino E
    J Thromb Haemost; 2012 Apr; 10(4):716-9. PubMed ID: 22934293
    [No Abstract]   [Full Text] [Related]  

  • 57. Inhibition of thrombin generation by heparin and LMW heparins: a comparison of chromogenic and clotting methods.
    Houbouyan L; Padilla A; Gray E; Longstaff C; Barrowcliffe TW
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):24-30. PubMed ID: 8845459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serial urological interventions including circumcision in a hemophilic child with inhibitors.
    Leblebisatan G; Saşmaz I; Antmen B; Klnç Y; Aridoğan IA
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):547-8. PubMed ID: 21519231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of a novel covalent antithrombin-heparin complex on thrombin generation on fetal distal lung epithelium.
    Chan AK; Berry L; Mitchell L; Baranowski B; O'Brodovich H; Andrew M
    Am J Physiol; 1998 Jun; 274(6):L914-21. PubMed ID: 9609730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current anticoagulant therapy--unmet clinical needs.
    Hirsh J
    Thromb Res; 2003 Jul; 109 Suppl 1():S1-8. PubMed ID: 12818628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.